MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Treace Medical Concepts Inc

Cerrado

1.8 17.65

Resumen

Variación precio

24h

Actual

Mínimo

1.5

Máximo

2.13

Métricas clave

By Trading Economics

Ingresos

6.9M

-9.4M

Ventas

12M

63M

Margen de beneficios

-15.026

Empleados

450

EBITDA

7M

-5.2M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+125.41% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-35M

93M

Apertura anterior

-15.85

Cierre anterior

1.8

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 abr 2026, 17:04 UTC

Principales Movimientos del Mercado

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 abr 2026, 00:00 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Big Yachts, Big Bucks -- Barrons.com

10 abr 2026, 21:55 UTC

Adquisiciones, fusiones, absorciones

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 abr 2026, 21:01 UTC

Ganancias

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

10 abr 2026, 20:31 UTC

Charlas de Mercado

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 abr 2026, 20:10 UTC

Adquisiciones, fusiones, absorciones

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 abr 2026, 19:15 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

10 abr 2026, 19:15 UTC

Charlas de Mercado

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 abr 2026, 18:38 UTC

Charlas de Mercado

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 abr 2026, 18:25 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Precious Metals Finish With Weekly Gains -- Market Talk

10 abr 2026, 18:05 UTC

Charlas de Mercado

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 abr 2026, 17:31 UTC

Charlas de Mercado
Noticias de Eventos Importantes

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 abr 2026, 17:26 UTC

Ganancias

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 abr 2026, 17:10 UTC

Charlas de Mercado

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 abr 2026, 17:00 UTC

Noticias de Eventos Importantes

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 abr 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

10 abr 2026, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

10 abr 2026, 16:12 UTC

Ganancias

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 abr 2026, 16:11 UTC

Ganancias

Partners Group: Traditional Programs Contributed $3.3B

10 abr 2026, 16:10 UTC

Ganancias

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 abr 2026, 16:10 UTC

Ganancias

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 abr 2026, 16:10 UTC

Ganancias

Partners Group 1Q New Client Demand $8.3B

10 abr 2026, 16:09 UTC

Ganancias

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 abr 2026, 15:54 UTC

Adquisiciones, fusiones, absorciones

Plenitude Completes Acquisition of Acea Energia

10 abr 2026, 15:38 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Treace Medical Concepts Inc previsión

Precio Objetivo

By TipRanks

125.41% repunte

Estimación a 12 Meses

Media 4.08 USD  125.41%

Máximo 7 USD

Mínimo 2.25 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

7.16 / 7.65Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat